Total Payments
$2,160
2024 Payments
$127.41
Companies
23
Transactions
100
Medicare Patients
2,351
Medicare Billing
$412,205
Payment Breakdown by Category
Food & Beverage$2,130 (98.6%)
Education$29.99 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,130 | 99 | 98.6% |
| Education | $29.99 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $417.83 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $345.45 | 27 | $0 (2019) |
| ViiV Healthcare Company | $256.17 | 17 | $0 (2019) |
| Janssen Products, LP | $234.40 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $125.65 | 8 | $0 (2019) |
| Gilead Sciences, Inc. | $111.75 | 8 | $0 (2019) |
| TETRAPHASE PHARMACEUTICALS, INC. | $105.48 | 3 | $0 (2019) |
| AbbVie, Inc. | $102.42 | 1 | $0 (2018) |
| Allergan, Inc. | $100.65 | 6 | $0 (2020) |
| Melinta Therapeutics, Inc. | $52.56 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $127.41 | 1 | La Jolla Pharmaceutical Company ($127.41) |
| 2023 | $110.94 | 1 | La Jolla Pharmaceutical Company ($110.94) |
| 2022 | $90.12 | 1 | La Jolla Pharmaceutical Company ($90.12) |
| 2021 | $89.36 | 1 | La Jolla Pharmaceutical Company ($89.36) |
| 2020 | $17.44 | 1 | Allergan, Inc. ($17.44) |
| 2019 | $732.45 | 41 | Merck Sharp & Dohme Corporation ($157.07) |
| 2018 | $669.57 | 38 | Merck Sharp & Dohme Corporation ($131.19) |
| 2017 | $323.19 | 16 | Janssen Products, LP ($102.41) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/31/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $127.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/18/2023 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $110.94 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 02/09/2022 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $90.12 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 09/08/2021 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $89.36 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 02/13/2020 | Allergan, Inc. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/26/2019 | Mayne Pharma Inc. | DORYX (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: DERMATOLOGY | ||||||
| 09/20/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/19/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/03/2019 | Theratechnologies Inc. | TROGARZO (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: HIV | ||||||
| 08/29/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Respiratory | ||||||
| 08/27/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/22/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.28 | General |
| 08/13/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 08/08/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: HIV | ||||||
| 08/06/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 08/01/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/31/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: HIV | ||||||
| 07/25/2019 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Pharma Product | ||||||
| 07/23/2019 | Mayne Pharma Inc. | DORYX (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: DERMATOLOGY | ||||||
| 07/13/2019 | Seqirus USA Inc | Fluad (Biological) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Vaccines | ||||||
| 06/12/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/10/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/06/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/05/2019 | Horizon Therapeutics plc | ACTIMMUNE (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: ACTIMMUNE | ||||||
| 06/04/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 433 | 869 | $190,380 | $73,922 |
| 2022 | 6 | 477 | 1,034 | $240,580 | $84,873 |
| 2021 | 6 | 589 | 1,252 | $303,000 | $107,313 |
| 2020 | 7 | 852 | 1,662 | $390,876 | $146,098 |
Total Patients
2,351
Total Services
4,817
Medicare Billing
$412,205
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 139 | 404 | $56,560 | $23,857 | 42.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 88 | 208 | $41,600 | $18,671 | 44.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 98 | 105 | $33,600 | $13,173 | 39.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 27 | 64 | $37,760 | $10,219 | 27.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 59 | 59 | $15,930 | $5,387 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 29 | $4,930 | $2,615 | 53.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 165 | 531 | $74,340 | $28,047 | 37.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 48 | 130 | $76,700 | $20,613 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 84 | 181 | $36,200 | $13,803 | 38.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 75 | 78 | $24,960 | $11,316 | 45.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 85 | 90 | $24,300 | $8,977 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 24 | $4,080 | $2,116 | 51.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 193 | 573 | $80,220 | $29,725 | 37.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 62 | 175 | $103,250 | $28,275 | 27.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 100 | 255 | $51,000 | $20,417 | 40.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 86 | 90 | $28,800 | $13,689 | 47.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 122 | 127 | $34,290 | $12,732 | 37.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 32 | $5,440 | $2,474 | 45.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 283 | 785 | $109,900 | $43,674 | 39.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 69 | 192 | $113,280 | $32,886 | 29.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 143 | 311 | $62,200 | $25,029 | 40.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 130 | 132 | $42,240 | $20,537 | 48.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 184 | 192 | $51,840 | $19,825 | 38.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 38 | $6,460 | $2,442 | 37.8% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 11 | 12 | $4,956 | $1,705 | 34.4% |
About Chad Tewell
Chad Tewell is a Infectious Disease healthcare provider based in Carmel, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2011. The National Provider Identifier (NPI) number assigned to this provider is 1497046452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chad Tewell has received a total of $2,160 in payments from pharmaceutical and medical device companies, with $127.41 received in 2024. These payments were reported across 100 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,130).
As a Medicare-enrolled provider, Tewell has provided services to 2,351 Medicare beneficiaries, totaling 4,817 services with total Medicare billing of $412,205. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Carmel, IN
- Active Since 04/26/2011
- Last Updated 07/27/2016
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1497046452
Products in Payments
- XERAVA (Drug) $290.42
- Symtuza (Drug) $211.56
- ISENTRESS (Drug) $182.90
- XACDURO (Drug) $127.41
- Xerava (Drug) $105.48
- Mavyret (Drug) $102.42
- JULUCA (Drug) $96.41
- TRIUMEQ (Drug) $78.65
- ZERBAXA (Drug) $76.36
- DOVATO (Drug) $61.08
- DALVANCE (Drug) $51.86
- AVYCAZ (Drug) $48.79
- PREZCOBIX (Drug) $46.08
- DIFICID (Drug) $43.20
- Baxdela (Drug) $34.95
- DORYX (Drug) $34.71
- ACTIMMUNE (Drug) $30.61
- CUVITRU (Biological) $29.65
- Daraprim Tablet 25mg (Drug) $27.69
- NOXAFIL (Drug) $26.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Carmel
Markian Bochan, Md, MD
Infectious Disease — Payments: $180,977
Infectious Disease $180,977
Francisco Delgado, M.d, M.D
Infectious Disease — Payments: $55,789
Infectious Disease $55,789
Tracey Ikerd, Md, MD
Infectious Disease — Payments: $54,660
Infectious Disease $54,660
Dr. Hassan Elmalik, Md, MD
Infectious Disease — Payments: $1,875
Infectious Disease $1,875
Dr. Joshua Berg, M.d, M.D
Infectious Disease — Payments: $1,401
Infectious Disease $1,401
Joseph Fraiz, Md, MD
Infectious Disease — Payments: $1,031
Infectious Disease $1,031